Verastem, Inc. VSTM

As no insider buy has been placed there is no trust in their performance. DO NOT even think in getting in?

When RS again?

Bottom here has no limit, bravo!

Give me $2

Still space to fall?

Btw: $0.30 pre-RS?

Assuming 1Y target 24$ and 10times increase with good news there is still place to fall to SP $2,4?

Orchestrated robbery ?

Btw: $0.34 pre-RS ...

On May 24, 2024, Verastem, Inc. (the “Company” or “Verastem”) issued a press release announcing the initiation of a rolling submission of a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for Accelerated Approval of the combination of avutometinib and defactinib for adult patients with recurrent KRAS mutant (“KRAS mt”) low-grade serious ovarian cancer (“LGSOC”);